Race and Alzheimer Disease Biomarkers: A Neglected Race.
作者信息
Lleó Alberto, Suárez-Calvet Marc
机构信息
Memory Unit (A.L.), Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau-Universitat Autònoma de Barcelona; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED) (A.L.), Madrid; Barcelonaβeta Brain Research Center (BBRC) (M.S.-C.), Pasqual Maragall Foundation, Barcelona; Servei de Neurologia (M.S.-C.), Hospital del Mar, Barcelona; IMIM (Hospital del Mar Medical Research Institute) (M.S.-C.), Barcelona; and Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) (M.S.-C.), Madrid, Spain.
出版信息
Neurol Genet. 2021 Mar 4;7(2):e574. doi: 10.1212/NXG.0000000000000574. eCollection 2021 Apr.
Abstract
摘要
相似文献
1
Race and Alzheimer Disease Biomarkers: A Neglected Race.种族与阿尔茨海默病生物标志物：一个被忽视的种族。
Neurol Genet. 2021 Mar 4;7(2):e574. doi: 10.1212/NXG.0000000000000574. eCollection 2021 Apr.
2
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.评估阿尔茨海默病生物标志物的种族差异。
JAMA Neurol. 2019 Mar 1;76(3):264-273. doi: 10.1001/jamaneurol.2018.4249.
3
Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors.血浆和脑脊液阿尔茨海默病生物标志物与种族的关联，以及遗传背景、血管合并症和社区因素的作用。
JAMA Netw Open. 2022 Oct 3;5(10):e2235068. doi: 10.1001/jamanetworkopen.2022.35068.
4
A test of lens opacity as an indicator of preclinical Alzheimer Disease.一项以晶状体混浊作为临床前阿尔茨海默病指标的测试。
Exp Eye Res. 2015 Nov;140:117-123. doi: 10.1016/j.exer.2015.03.010. Epub 2015 Mar 13.
5
Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review.种族报告和阿尔茨海默病临床试验中的差异：系统评价。
Neurosci Biobehav Rev. 2019 Jun;101:122-128. doi: 10.1016/j.neubiorev.2019.03.020. Epub 2019 Apr 1.
6
Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US.美国按性别、种族和族裔划分的与阿尔茨海默病及相关痴呆症相关的风险因素。
JAMA Neurol. 2022 Jun 1;79(6):584-591. doi: 10.1001/jamaneurol.2022.0976.
7
The Dark Side of Alzheimer's Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level.阿尔茨海默病的阴暗面：被忽视的大脑过度兴奋和意识水平异常的生理生物标志物。
J Alzheimers Dis. 2022;88(3):801-807. doi: 10.3233/JAD-220582.
8
Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research.避免重蹈历史覆辙：关于在阿尔茨海默病和阿尔茨海默病相关痴呆症研究中使用种族问题，给科学家的两点警示。
J Alzheimers Dis. 2023;92(3):729-740. doi: 10.3233/JAD-220507.
9
Emerging ocular biomarkers of Alzheimer disease.阿尔茨海默病新出现的眼部生物标志物。
Clin Exp Ophthalmol. 2017 Jan;45(1):54-61. doi: 10.1111/ceo.12872. Epub 2016 Dec 19.
10
[Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer's Dementia].[用于优化阿尔茨海默病痴呆早期及鉴别诊断的血液生物标志物]
Fortschr Neurol Psychiatr. 2022 Jul;90(7-08):326-335. doi: 10.1055/a-1839-6237. Epub 2022 Jul 20.
引用本文的文献
1
Novel Alzheimer's disease genes and epistasis identified using machine learning GWAS platform.利用机器学习 GWAS 平台鉴定新型阿尔茨海默病基因及其上位性。
Sci Rep. 2023 Oct 17;13(1):17662. doi: 10.1038/s41598-023-44378-y.
2
New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia.基于生物流体的生物标志物在额颞叶痴呆的常规诊断和疾病轨迹中的新进展。
Alzheimers Dement. 2022 Nov;18(11):2292-2307. doi: 10.1002/alz.12643. Epub 2022 Mar 2.
本文引用的文献
1
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants.非裔美国人脑脊液中可溶性触发受体表达分子2（TREM2）及相关基因变体存在差异。
Neurol Genet. 2021 Mar 4;7(2):e571. doi: 10.1212/NXG.0000000000000571. eCollection 2021 Apr.
2
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model.抗人 TREM2 诱导小胶质细胞增殖并减少阿尔茨海默病模型中的病理。
J Exp Med. 2020 Sep 7;217(9). doi: 10.1084/jem.20200785.
3
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease.脑脊液中可溶性 TREM2 的增加与阿尔茨海默病认知和临床衰退的减少有关。
Sci Transl Med. 2019 Aug 28;11(507). doi: 10.1126/scitranslmed.aav6221.
4
TREM2 - a key player in microglial biology and Alzheimer disease.TREM2 - 小胶质细胞生物学和阿尔茨海默病的关键因素。
Nat Rev Neurol. 2018 Nov;14(11):667-675. doi: 10.1038/s41582-018-0072-1.
5
Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.种族改变了认知与阿尔茨海默病脑脊液生物标志物之间的关系。
Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.
6
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury.在显性遗传性阿尔茨海默病中，CSF sTREM2 的早期变化发生在淀粉样蛋白沉积和神经元损伤之后。
Sci Transl Med. 2016 Dec 14;8(369):369ra178. doi: 10.1126/scitranslmed.aag1767.
7
Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults.老年黑人和白人成年人心血管危险因素发生率的种族差异。
J Am Geriatr Soc. 2017 Jan;65(1):83-90. doi: 10.1111/jgs.14472. Epub 2016 Sep 26.
8
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.可溶性触发受体2（sTREM2）脑脊液水平是早期阿尔茨海默病中小胶质细胞活性的潜在生物标志物，并与神经元损伤标志物相关。
EMBO Mol Med. 2016 May 2;8(5):466-76. doi: 10.15252/emmm.201506123. Print 2016 May.
9
Inequalities in dementia incidence between six racial and ethnic groups over 14 years.14年间六个种族和民族群体在痴呆症发病率上的不平等。
Alzheimers Dement. 2016 Mar;12(3):216-24. doi: 10.1016/j.jalz.2015.12.007. Epub 2016 Feb 11.
10
Systemic inflammation and disease progression in Alzheimer disease.阿尔茨海默病中的全身炎症与疾病进展
Neurology. 2009 Sep 8;73(10):768-74. doi: 10.1212/WNL.0b013e3181b6bb95.
Zotero 插件